- Home
- LEDS vs IMNN Comparison
LEDS vs IMNN Comparison
Compare LEDS & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEDS
- IMNN
- Stock Information
- Founded
- LEDS 2005
- IMNN 1982
- Country
- LEDS Taiwan
- IMNN United States
- Employees
- LEDS N/A
- IMNN N/A
- Industry
- LEDS Semiconductors
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- LEDS Technology
- IMNN Health Care
- Exchange
- LEDS Nasdaq
- IMNN Nasdaq
- Market Cap
- LEDS 13.6M
- IMNN 12.1M
- IPO Year
- LEDS 2010
- IMNN 1985
- Fundamental
- Price
- LEDS $1.81
- IMNN $7.08
- Analyst Decision
- LEDS
- IMNN Buy
- Analyst Count
- LEDS 0
- IMNN 2
- Target Price
- LEDS N/A
- IMNN $210.00
- AVG Volume (30 Days)
- LEDS 35.1K
- IMNN 500.6K
- Earning Date
- LEDS 07-11-2025
- IMNN 08-05-2025
- Dividend Yield
- LEDS N/A
- IMNN N/A
- EPS Growth
- LEDS N/A
- IMNN N/A
- EPS
- LEDS N/A
- IMNN N/A
- Revenue
- LEDS $31,108,000.00
- IMNN N/A
- Revenue This Year
- LEDS N/A
- IMNN N/A
- Revenue Next Year
- LEDS N/A
- IMNN N/A
- P/E Ratio
- LEDS N/A
- IMNN N/A
- Revenue Growth
- LEDS 485.62
- IMNN N/A
- 52 Week Low
- LEDS $0.92
- IMNN $4.83
- 52 Week High
- LEDS $3.16
- IMNN $41.22
- Technical
- Relative Strength Index (RSI)
- LEDS 42.89
- IMNN 42.63
- Support Level
- LEDS $1.41
- IMNN $6.45
- Resistance Level
- LEDS $1.64
- IMNN $8.19
- Average True Range (ATR)
- LEDS 0.14
- IMNN 0.83
- MACD
- LEDS 0.00
- IMNN 0.30
- Stochastic Oscillator
- LEDS 57.39
- IMNN 56.08
About LEDS SemiLEDS Corporation
SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).